Via: Businesswire.com
Ocular Therapeutix™ to Present at the Jefferies 2019 London Healthcare Conference
Ocular Therapeutix™ to Present at the Jefferies 2019 London Healthcare Conference
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on
the formulation, development, and commercialization of innovative therapies
for diseases and conditions of the eye, today announced that Donald Notman,
Chief Financial Officer of Ocular Therapeutix, will give a company
presentation on Thursday, November 21^st at 8:40 a.m. GMT at the Jefferies
2019 London Healthcare Conference being held at the Waldorf Hilton in London,
UK.
Read More: https://www.businesswire.com/news/home/20191114005159/en/
RSS Feed
